Contents
Issue 122 • September 2022
In association with
In association with
Comment
Tapping into pharma’s growing opportunities in digital health
Covid-19 Omicron boosters will reinvigorate injectables manufacturing
Implementation of electronic health records will improve the quality of care
Despite benefits, long-acting injectables remain underutilised for schizophrenia
Coherus’ Cimerli bags approval for DME with year-long interchangeability exclusivity
UK health data collaboration paves the way to study Long Covid symptoms
In Depth
NICE makeover: a new look for UK HTAs
No drugs for prions: quelling therapeutic scarcity
Getting smart with digital pills
Can generics producers tackle complex and specialty drugs?
Decentralised paediatric clinical trials trending up but study execution critical
CMO Moves: Regulatory catalysts for drug manufacturing- August
In Data
Healthtech deals decreased significantly in the pharma industry in H1 2022
North America sees a hiring boom in industry machine learning roles
Artificial intelligence mentions decrease in pharma filings in Q2 of 2022
Digital media hiring levels in the pharmaceutical industry rose in June 2022
Comment
Tapping into pharma’s growing opportunities in digital health